ArticleMaterials today. Bio2026
Microfluidic 3D-printed MSC-laden bioactive hydrogel for intrauterine adhesion prevention and endometrial regeneration.
Article in Materials today. Bio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Adipose-derived extracellular vesicles miR-423-5p targets SMAD3 to reverse endometrial fibrosis in a porcine model of intrauterine adhesion: insights from single-cell sequencing.Materials today. Bio · 2026Article
- Engineering Hydrogels for Intrauterine Adhesion Therapy and Endometrial Regeneration.Gels (Basel, Switzerland) · 2026Review
- Hydrogel-Based Systems in Intrauterine Adhesions: Bridging the Gap from Bench to Bedside.Advanced healthcare materials · 2026Review
- Pharmaceutical therapies for pyroptosis in lung injury.Inflammopharmacology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Increasing occurrence of intrauterine adhesion (IUA) is a serious threat to the reproductive health of women in recent years. However, treatment options remain limited. Mesenchymal stem cell (MSC)-based therapies have shown a promising regenerative capacity of injured endometrium but have limited effectiveness by the low survival duration of transplanted cells. Herein, we present a bioactive hydrogel scaffold loaded with adipose tissue-derived MSC (AT-MSC) by using a three-dimensional (3D) bioprinting technology, which combines the characteristics of the synthetic thermos-responsive material PF-127 and the natural-derived, photo-polymerizable material GelMA. The composite hydrogel scaffold shows enhanced mechanical as well as biocompatibility. In addition, the porous structure endows the 3D-printed scaffold with a favorable growing environment for MSC and increase the retention rate of cells. Finally, the dual repair effects of the MSC-laden gel scaffold on endometrial damage and regeneration are validated in a rat IUA model. This study demonstrates that the composite system could improve neovascularization, increase number of glands, and ameliorate fibrotic formation of endometrium. Thus, it is believed that such bioactive MSC-loaded scaffold is a promising candidate for prevention of IUA with reliable endometrial regeneration properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.